Related Experiment Video
Updated: May 16, 2025
07:29
Author Spotlight: Exploring the Mechanisms of MicroRNA Loading into Extracellular Vesicles in Cancer Progression
Published on: October 6, 2023
1.4K
Ribosomal rebellion: When protein factories drive cancer progression
Qiushuang Wu1, Sohail F Tavazoie1
1Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.
Cancer Cell
|April 25, 2025
Summary
Two studies reveal how cancer hijacks protein synthesis. One shows enhanced translation initiation drives cancer, while the other links transfer RNA (tRNA) modification errors to neoantigen production for cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Cancer cells exploit cellular machinery for growth.
- Protein synthesis is a key target for cancer therapies.
- Aberrant translation contributes to oncogenesis.
Purpose of the Study:
- To elucidate mechanisms of protein synthesis machinery co-option in cancer.
- To identify potential therapeutic targets within these pathways.
- To understand the role of translation in generating cancer-specific antigens.
Main Methods:
- Investigated the role of eukaryotic initiation factor 4A (eIF4A) in oncogenic transcript translation.
- Analyzed transfer RNA (tRNA) modifications and their impact on translational fidelity.
- Utilized cancer models to study the functional consequences of altered protein synthesis.
Main Results:
- eIF4A-mediated enhancement of translation initiation promotes cancer progression.
- Defective tRNA modification leads to translational errors and neoantigen formation.
- These findings highlight critical nodes in cancer development and immune evasion.
Conclusions:
- Targeting protein synthesis initiation offers a therapeutic strategy for cancer.
- Understanding tRNA modification defects can inform novel cancer immunotherapy approaches.
- Co-option of the translational machinery is a fundamental aspect of cancer biology.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:55The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:24Ribosome Profiling
3.4K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.4K
01:27Ribosomes
7.1K
Ribosomes translate genetic information encoded by messenger RNA (mRNA) into proteins. Both prokaryotic and eukaryotic cells have ribosomes. Cells that synthesize large quantities of protein—such as secretory cells in the human pancreas—can contain millions of ribosomes.
Ribosome Structure and Assembly
Ribosomes are composed of ribosomal RNA (rRNA) and proteins. In eukaryotes, rRNA is transcribed from genes in the nucleolus—a part of the nucleus that specializes in ribosome...
Ribosome Structure and Assembly
Ribosomes are composed of ribosomal RNA (rRNA) and proteins. In eukaryotes, rRNA is transcribed from genes in the nucleolus—a part of the nucleus that specializes in ribosome...
7.1K
01:31Translation
14.2K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.2K